![Mark Lanasa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lanasa
Corporate Officer/Principal bei
BEIGENE LTD
Profil
Mark Lanasa currently works at BeOne Medicines Ltd., as Chief Medical Officer-Solid Tumors & SVP from 2022.
Mr. Lanasa also formerly worked at AstraZeneca PLC, as Vice President & Head-Enhertu Global Clinical from 2019 to 2022.
Mr. Lanasa received his undergraduate degree from The Pennsylvania State University and graduate degree and doctorate degree from the University of Pittsburgh School of Medicine.
Aktive Positionen von Mark Lanasa
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | Corporate Officer/Principal | 09.02.2022 |
Ehemalige bekannte Positionen von Mark Lanasa
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2022 |
Ausbildung von Mark Lanasa
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
